Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

被引：9
|
作者：
Turlure, Pascal [1 ]
Cambier, Nathalie [2 ]
Roussel, Murielle [3 ]
Bellucci, Sylvia [4 ]
Zini, Jean-Marc
Rain, Jean-Didier
Rousselot, Philippe [5 ]
Vainchenker, William [6 ]
Abdelkader, Lina
Ghomari, Kamel [7 ]
Dutel, Jean-Luc [7 ]
Chait, Yasmine [8 ]
Chevret, Sylvie [9 ]
Chomienne, Christine [10 ]
Cassinat, Bruno [11 ]
Kiladjian, Jean-Jacques [12 ]
机构：
[1] CHU, Serv Hematol Clin, Limoges, France
[2] CHRU Lille, Serv Hematol, Lille, France
[3] Hop Purpan, Hematol Clin, Toulouse, France
[4] Hop Lariboisiere, F-75475 Paris, France
[5] Univ Versailles St Quentin Yvelines, Hop Versailles, Le Chesnay, France
[6] Univ Paris 06, INSERM, U1009, Inst Gustave Roussy, Villejuif, France
[7] CH Beauvais, Serv Hematol, Beauvais, France
[8] CH Montfermeil, Serv Hematol, Montfermeil, France
[9] Univ Paris 07, Hop St Louis, AP HP, Paris, France
[10] Inst Univ Hematol, INSERM, UMR S 940, Paris, France
[11] Hop St Louis, Unite Biol Cellulaire, Paris, France
[12] Hop St Louis, CIC, Paris, France
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
10.1182/blood.V118.21.280.280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：129 / 130
页数：2
相关论文
共 30 条
  • [1] Treatment with pegylated Interferon-Atfa-2A (PEG-IFN-Aα-2A; PEGASYS™) for patients with essential thrombocythemia (ET) and polycythemia vera (PV).
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Giles, Francis
    Cortes, Jorge
    Richie, Mary Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2006, 108 (11) : 307B - 307B
  • [2] Peg IFNα-2a in polycythemia vera (PV).: Results of a phase 2 study by the French "PV-NORD" group.
    Kiladjian, Jean-Jacques
    Cassinat, Bruno
    Turlure, Pascal
    Cambier, Nathalie
    Bellucci, Sylvia
    Roussel, Murielle
    Grange, Marie-Jose
    Grandchamp, Bernard
    Rain, Jean-Didier
    Chomienne, Christine
    Fenaux, Pierre
    [J]. BLOOD, 2006, 108 (11) : 757A - 757A
  • [3] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [4] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Lucia Masarova
    C. Cameron Yin
    Jorge E. Cortes
    Marina Konopleva
    Gautam Borthakur
    Kate J. Newberry
    Hagop M. Kantarjian
    Carlos E. Bueso-Ramos
    Srdan Verstovsek
    [J]. Experimental Hematology & Oncology, 6
  • [5] Pegylated interferon-alfa-2a (PEG-IFN-α-2A; PEGASYSTM) for essential thrombocythemia (ET) and polycythemia vera (PV):: An update of an ongoing phase II study
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2007, 110 (11) : 1036A - 1037A
  • [6] PEGYLATED INTERFERON-α-2A INDUCES COMPLETE HEMATOLOGICAL AND MOLECULAR RESPONSES WITH LOW TOXICITY IN POLYCYTHEMIA VERA: RESULTS OF THE PV-NORD PVN1 STUDY
    Kiladjian, J. J.
    Cassinat, B.
    Turlure, P.
    Cambier, N.
    Roussel, M.
    Bellucci, S.
    Chevret, S.
    Grandchamp, B.
    Chomienne, C.
    Fenaux, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 180 - 180
  • [7] Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)
    Quintas-Cardania, Alfonso
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2008, 112 (11) : 246 - 246
  • [8] High Rates of Molecular Response After Long-Term Follow-up of Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia Vera (PV) Treated With Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGA-SYS)
    Quintas-Cardama, Alfonso
    Levine, Ross
    Manshouri, Taghi
    Kilpivaara, Outi
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2010, 116 (21) : 206 - 206
  • [9] Dynamics of Mutant Alleles in Patients with Advanced Essential Thrombocythernia (ET) or Polycythemia (PV) During Pegylated Interferon-Alfa-2A (PEG-IFN-α-2A; Pegasys) Therapy
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Levine, Ross L.
    Manshouri, Taghi
    Roupie, Anne-Laure
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2011, 118 (21) : 130 - 130
  • [10] Long term results after therapy with pegylated interferon alpha 2a in HCV positive liver transplant recipients
    Bahra, M
    Neumann, UP
    Jacob, D
    Langrehr, JM
    Neuhaus, R
    Neuhaus, P
    [J]. HEPATOLOGY, 2005, 42 (04) : 488A - 489A
123